Translate
Keros Therapeutics Inc
About
Keros Therapeutics Inc (NASDAQ:KROS) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 9 2026
Keros Therapeutics Announces Collaboration with Sean M. Healey & AMG Center for ALS
Mar 4 2026
Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
Feb 26 2026
Keros Therapeutics Appoints Charles Newton to its Board of Directors
Nov 20 2025
Keros Therapeutics Announces Final Results of Tender Offer
Nov 19 2025
Keros Therapeutics Announces Preliminary Results of Tender Offer
Financials
Revenue
$244.06 M
Market Cap
$361.63 M
P/E Ratio
5.16
EPS
2.30